| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699270 | Clinical Oncology | 2011 | 7 Pages |
Abstract
The optimal chemotherapy utilisation rate can serve as an evidence-based benchmark in the planning and evaluation of chemotherapy services for brain cancer. There are no recent published patterns of care studies that report on chemotherapy utilisation rates for primary malignant brain tumours; future research should focus on filling this gap.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Jacob, W. Ng, G.P. Delaney, M.B. Barton,